The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hebert, C. A.
Right arrow Articles by Baker, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hebert, C. A.
Right arrow Articles by Baker, J. B.

The Journal of Immunology, Vol 145, Issue 9 3033-3040, Copyright © 1990 by American Association of Immunologists


ARTICLES

Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils

CA Hebert, FW Luscinskas, JM Kiely, EA Luis, WC Darbonne, GL Bennett, CC Liu, MS Obin, MA Gimbrone Jr and JB Baker
Genentech, Inc., South San Francisco, CA 94080.

We have recently shown that endothelial cell-derived IL-8 inhibits neutrophil adhesion to IL1-beta-activated human umbilical vein endothelial cell monolayers. IL-8 secreted by T lymphocytes or monocytes has been characterized as a promoter of neutrophil degranulation and chemotaxis. The IL-8 isolated from each of these cell types is a mixture of two IL-8 polypeptides, one consisting of 72 amino acids (herein called [ser-IL-8]72) and the other 77 amino acids (an N- terminal extended form herein called [ala-IL-8]77). IL-8 derived from T lymphocytes and monocytes is predominantly [ser-IL-8]72, whereas endothelial-derived IL-8 is highly enriched (greater than 80%) in [ala- IL-8]77. We address the relationship and activities of these two forms of IL-8 using recombinant proteins expressed by both mammalian cells and Escherichia coli. Thrombin was found to efficiently convert [ala-IL- 8]77 to [ser-IL-8]72. In contrast, urokinase and tissue-type plasminogen activator were unable to cleave [ala-IL-8]77, and trypsin generated multiple IL-8 cleavage fragments. In competitive binding assays using 125I[ala-IL-8]77 neutrophils exhibited a twofold preference for [ser-IL-8]72 over [ala-IL-8]77. Both forms of IL-8 inhibited neutrophil adhesion to IL-1-beta-activated HUVEC monolayers by up to 90%. However, [ser-IL-8]72 was approximately 10-fold more potent than [ala-IL-8]77 in these assays (ED50 approximately 0.3 nM for [ser-IL-8]72 vs approximately 3 nM for [ala-IL-8]77. Both forms of IL-8 promoted degranulation of cytochalasin B-treated neutrophils [[ser-IL- 8]72 (ED50 greater than 10 nM) was two- to three-fold more potent than [ala-IL-8]77], although in this regard they were less active than FMLP. Our data suggest that [ala-IL-8]77 and [ser-IL-8]72 have qualitatively similar and potentially complex biological activities, and that full activation of IL-8 requires cleavage to the [ser-IL-8]72 form. In the case of inflamed endothelial cells this activation could be mediated by thrombin generated in the procoagulant environment associated with these cells.


This article has been cited by other articles:


Home page
haematolHome page
T. Loos, G. Opdenakker, J. Van Damme, and P. Proost
Citrullination of CXCL8 increases this chemokine's ability to mobilize neutrophils into the blood circulation
Haematologica, October 1, 2009; 94(10): 1346 - 1353.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Hol, A. M. Kuchler, F.-E. Johansen, B. Dalhus, G. Haraldsen, and I. Oynebraten
Molecular Requirements for Sorting of the Chemokine Interleukin-8/CXCL8 to Endothelial Weibel-Palade Bodies
J. Biol. Chem., August 28, 2009; 284(35): 23532 - 23539.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Loos, A. Mortier, M. Gouwy, I. Ronsse, W. Put, J.-P. Lenaerts, J. Van Damme, and P. Proost
Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation
Blood, October 1, 2008; 112(7): 2648 - 2656.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
P. Proost, T. Loos, A. Mortier, E. Schutyser, M. Gouwy, S. Noppen, C. Dillen, I. Ronsse, R. Conings, S. Struyf, et al.
Citrullination of CXCL8 by peptidylarginine deiminase alters receptor usage, prevents proteolysis, and dampens tissue inflammation
J. Exp. Med., September 1, 2008; 205(9): 2085 - 2097.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Skov, F. J. Beurskens, C. O. C. Zachariae, S. Reitamo, J. Teeling, D. Satijn, K. M. Knudsen, E. P. J. Boot, D. Hudson, O. Baadsgaard, et al.
IL-8 as Antibody Therapeutic Target in Inflammatory Diseases: Reduction of Clinical Activity in Palmoplantar Pustulosis
J. Immunol., July 1, 2008; 181(1): 669 - 679.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
I. H. K. Dias, L. Marshall, P. A. Lambert, I. L. C. Chapple, J. B. Matthews, and H. R. Griffiths
Gingipains from Porphyromonas gingivalis Increase the Chemotactic and Respiratory Burst-Priming Properties of the 77-Amino-Acid Interleukin-8 Variant
Infect. Immun., January 1, 2008; 76(1): 317 - 323.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Moscova, D. J. Marsh, and R. C. Baxter
Protein Chip Discovery of Secreted Proteins Regulated by the Phosphatidylinositol 3-Kinase Pathway in Ovarian Cancer Cell Lines
Cancer Res., February 1, 2006; 66(3): 1376 - 1383.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. D. Berahovich, Z. Miao, Y. Wang, B. Premack, M. C. Howard, and T. J. Schall
Proteolytic Activation of Alternative CCR1 Ligands in Inflammation
J. Immunol., June 1, 2005; 174(11): 7341 - 7351.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E.-Y. Choi, E.-C. Kim, H.-M. Oh, S. Kim, H.-J. Lee, E.-Y. Cho, K.-H. Yoon, E.-A Kim, W.-C. Han, S.-C. Choi, et al.
Iron Chelator Triggers Inflammatory Signals in Human Intestinal Epithelial Cells: Involvement of p38 and Extracellular Signal-Regulated Kinase Signaling Pathways
J. Immunol., June 1, 2004; 172(11): 7069 - 7077.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. Mukaida
Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases
Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L566 - L577.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Valenzuela-Fernandez, T. Planchenault, F. Baleux, I. Staropoli, K. Le-Barillec, D. Leduc, T. Delaunay, F. Lazarini, J.-L. Virelizier, M. Chignard, et al.
Leukocyte Elastase Negatively Regulates Stromal Cell-derived Factor-1 (SDF-1)/CXCR4 Binding and Functions by Amino-terminal Processing of SDF-1 and CXCR4
J. Biol. Chem., May 3, 2002; 277(18): 15677 - 15689.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
C. M. Arroyo, C. A. Broomfield, and B. E. Hackley Jr.
The Role of Interleukin-6 (IL-6) in Human Sulfur Mustard (HD) Toxicology
International Journal of Toxicology, September 1, 2001; 20(5): 281 - 296.
[Abstract] [PDF]


Home page
BloodHome page
P. E. Van den Steen, P. Proost, A. Wuyts, J. Van Damme, and G. Opdenakker
Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact
Blood, October 15, 2000; 96(8): 2673 - 2681.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. G. Sitrin, P. M. Pan, H. A. Harper, R. F. Todd III, D. M. Harsh, and R. A. Blackwood
Clustering of Urokinase Receptors (uPAR; CD87) Induces Proinflammatory Signaling in Human Polymorphonuclear Neutrophils
J. Immunol., September 15, 2000; 165(6): 3341 - 3349.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. K. Topham, H. J. Carveth, T. M. Mcintyre, S. M. Prescott, and G. A. Zimmerman
Human endothelial cells regulate polymorphonuclear leukocyte degranulation
FASEB J, June 1, 1998; 12(9): 733 - 746.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
K. Johnson, Y. Choi, E. DeGroot, I. Samuels, A. Creasey, and L. Aarden
Potential Mechanisms for a Proinflammatory Vascular Cytokine Response to Coagulation Activation
J. Immunol., May 15, 1998; 160(10): 5130 - 5135.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Proost, S. Struyf, M. Couvreur, J.-P. Lenaerts, R. Conings, P. Menten, P. Verhaert, A. Wuyts, and J. V. Damme
Posttranslational Modifications Affect the Activity of the Human Monocyte Chemotactic Proteins MCP-1 and MCP-2: Identification of MCP-2(6-76) as a Natural Chemokine Inhibitor
J. Immunol., April 15, 1998; 160(8): 4034 - 4041.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
R. Pal, A. Garzino-Demo, P. D. Markham, J. Burns, M. Brown, R. C. Gallo, and A. L. DeVico
Inhibition of HIV-1 Infection by the beta -Chemokine MDC
Science, October 24, 1997; 278(5338): 695 - 698.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. B. Lowman, P. H. Slagle, L. E. DeForge, C. M. Wirth, B. L. Gillece-Castro, J. H. Bourell, and W. J. Fairbrother
Exchanging Interleukin-8 and Melanoma Growth-stimulating Activity Receptor Binding Specificities
J. Biol. Chem., June 14, 1996; 271(24): 14344 - 14352.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Williams, N. Borkakoti, G. A. Bottomley, I. Cowan, A. G. Fallowfield, P. S. Jones, S. J. Kirtland, G. J. Price, and L. Price
Mutagenesis Studies of Interleukin-8
J. Biol. Chem., April 19, 1996; 271(16): 9579 - 9586.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zhao-hai, W. Zi-xuan, R. Horuk, J. Hesselgesser, L. Yan-chun, T. J. Hadley, and S. C. Peiper
The Promiscuous Chemokine Binding Profile of the Duffy Antigen/Receptor for Chemokines Is Primarily Localized to Sequences in the Amino-terminal Domain
J. Biol. Chem., November 3, 1995; 270(44): 26239 - 26245.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Daly, G. J. LaRosa, S. Dolich, T. E. Maione, S. Cooper, and H. E. Broxmeyer
High Activity Suppression of Myeloid Progenitor Proliferation by Chimeric Mutants of Interleukin 8 and Platelet Factor 4
J. Biol. Chem., October 6, 1995; 270(40): 23282 - 23292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Graber, A. E. I. Proudfoot, F. Talabot, A. Bernard, M. McKinnon, M. Banks, D. Fattah, R. Solari, M. C. Peitsch, and T. N. C. Wells
Identification of Key Charged Residues of Human Interleukin-5 in Receptor Binding and Cellular Activation
J. Biol. Chem., June 30, 1995; 270(26): 15762 - 15769.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. Dunlevy and J. Couchman
Interleukin-8 induces motile behavior and loss of focal adhesions in primary fibroblasts
J. Cell Sci., January 1, 1995; 108(1): 311 - 321.
[Abstract] [PDF]


Home page
LupusHome page
R. F. Holcombe, B. A. Baethge, R. E. Wolf, K. W. Betzing, R. M. Stewart, V. C. Hall, and M. Fukuda
Correlation of Serum Interleukin-8 and Cell Surface Lysosome-associated Membrane Protein with Clinical Disease Activity in Systemic Lupus Erythematosus
Lupus, April 1, 1994; 3(2): 97 - 102.
[Abstract] [PDF]


Home page
ScienceHome page
R Horuk, C. Chitnis, W. Darbonne, T. Colby, A Rybicki, T. Hadley, and L. Miller
A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor
Science, August 27, 1993; 261(5125): 1182 - 1184.
[Abstract] [PDF]


Home page
ScienceHome page
W. Holmes, J Lee, W. Kuang, G. Rice, and W. Wood
Structure and functional expression of a human interleukin-8 receptor
Science, September 13, 1991; 253(5025): 1278 - 1280.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1990 by The American Association of Immunologists, Inc. All rights reserved.